person

Sean C.

Country
Ireland
Department
Department of Radiation Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 7 partner sites.

Specializations

Radiation Oncology & Solid Tumors

Focuses on the application of radiation therapy for a broad spectrum of solid malignancies.

  • Breast Cancer (including HER2‑positive and triple‑negative subtypes)
  • Non‑Small Cell Lung Cancer (early and metastatic stages)
  • Ovarian and Fallopian Tube Cancers (platinum‑resistant and advanced)
  • Prostate Cancer (high‑risk localized and metastatic castration‑resistant)
  • Head and Neck Squamous Cell Carcinoma

These efforts aim to integrate advanced radiotherapeutic techniques with systemic therapies.

Hematologic Malignancies

Addresses malignant disorders of the blood and bone marrow with targeted therapeutic strategies.

  • Acute Lymphoblastic Leukaemia
  • Acute Myeloid Leukaemia (including IDH1‑mutant disease)
  • Chronic Lymphocytic Leukaemia
  • Mantle Cell Lymphoma
  • Multiple Myeloma (newly diagnosed and relapsed/refractory)
  • Myelodysplastic Syndromes
  • Polycythemia Vera (JAK2V617F‑positive)
  • Myelofibrosis

The program emphasizes innovative combinations of radiation, immunotherapy, and targeted agents.

Autoimmune & Renal Disorders

Targets immune‑mediated diseases affecting systemic and renal function.

  • Systemic Lupus Erythematosus
  • IgA Nephropathy
  • Anti‑GBM Antibody Disease (Goodpasture syndrome)
  • Primary Membranous Nephropathy
  • Polymyalgia Rheumatica
  • Eosinophilic Asthma

Research seeks disease‑modifying approaches to preserve organ function.

Infectious & Respiratory Diseases

Focuses on acute and chronic infections as well as respiratory conditions with high morbidity.

  • COVID‑19 (SARS‑CoV‑2 infection)
  • Monkeypox (mpox)
  • Chronic Obstructive Pulmonary Disease
  • Cystic Fibrosis
  • Severe Asthma (eosinophilic phenotype)

Efforts aim to improve outcomes through novel antiviral and anti‑inflammatory strategies.

Rare Genetic & Metabolic Conditions

Investigates uncommon hereditary disorders that impact cancer biology and systemic health.

  • CDKL5 Deficiency Disorder
  • Hereditary Hemochromatosis (homeostatic iron regulator gene‑related)
  • FGFR2b‑Overexpressing Gastric Cancer
  • IDH1‑Mutant Acute Myeloid Leukaemia
  • JAK2V617F‑Positive Polycythemia Vera

These studies explore precision‑medicine approaches tailored to molecular abnormalities.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.